bullish
Eoflow: Ozempic and Wegovy Reducing Need for Disposable Insulin Injection Devices + Ongoing Lawsuit?
1.2k Views05 Oct 2023 12:25
Eoflow's share price has dropped 27% lower than the proposed tender offer price of 30,000 won. In this insight, we discuss two major factors have negatively impacted Eoflow's share price recently.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »Loading
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Eoflow: Outlook After Trading Resumes on 16 November15 Nov 2023
- Medtronic's M&A of Eoflow Timeline Postponed25 Oct 2023
- Eoflow: Temporary Trading Suspension11 Oct 2023
- Eoflow: Ozempic and Wegovy Reducing Need for Disposable Insulin Injection Devices + Ongoing Lawsuit?05 Oct 2023
- EOFLOW/Medtronic Tender: Proposed Preliminary Injunction Is a Problem05 Oct 2023
- Eoflow's US Subsidiary (Nephria Bio)'s Technology in MXene Advanced Material20 Aug 2023
- Insulet's Lawsuit Against Eoflow, Medtronic's Tender Offer, and Eoflow's "Special Sauce"09 Aug 2023
x